Your browser doesn't support javascript.
loading
Standardization of organoid culture in cancer research.
Zhou, Changchun; Wu, Yuanbo; Wang, Zeyu; Liu, Yanli; Yu, Jiaqi; Wang, Weiping; Chen, Sunrui; Wu, Weihua; Wang, Jidong; Qian, Guowei; He, Aina.
Afiliação
  • Zhou C; Biobank, Cancer Research Center, Shandong Cancer Hospital, Shandong First Medical University, Shandong Academy of Medical Sciences, Jinan, Shandong, China.
  • Wu Y; Department of Ultrasound, Yangxin County People's Hospital, Huangshi, Hubei, China.
  • Wang Z; Department of Gastrointestinal Surgery, Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China.
  • Liu Y; Biobank, Cancer Research Center, Shandong Cancer Hospital, Shandong First Medical University, Shandong Academy of Medical Sciences, Jinan, Shandong, China.
  • Yu J; Biobank, Cancer Research Center, Shandong Cancer Hospital, Shandong First Medical University, Shandong Academy of Medical Sciences, Jinan, Shandong, China.
  • Wang W; Department of Pharmacology and Pharmacy, Dr. Li Dak-Sum Research Centre, The University of Hong Kong, Hong Kong, China.
  • Chen S; Shanghai OneTar Biomedicine, Shanghai, China.
  • Wu W; Shanghai OneTar Biomedicine, Shanghai, China.
  • Wang J; Shanghai OneTar Biomedicine, Shanghai, China.
  • Qian G; Department of Oncology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiaotong University, Shanghai, China.
  • He A; Department of Oncology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiaotong University, Shanghai, China.
Cancer Med ; 12(13): 14375-14386, 2023 07.
Article em En | MEDLINE | ID: mdl-37081739
Establishing a valid in vitro model to represent tumor heterogeneity and biology is critical but challenging. Tumor organoids are self-assembled three-dimensional cell clusters which are of great significance for recapitulating the histopathological, genetic, and phenotypic characteristics of primary tissues. The organoid has emerged as an attractive in vitro platform for tumor biology research and high-throughput drug screening in cancer medicine. Organoids offer unique advantages over cell lines and patient-derived xenograft models, but there are no standardized methods to guide the culture of organoids, leading to confusion in organoid studies that may affect accurate judgments of tumor biology. This review summarizes the shortcomings of current organoid culture methods, presents the latest research findings on organoid standardization, and proposes an outlook for organoid modeling.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Cancer Med Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Cancer Med Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China